VIVOTEK's consolidated sales revenues for March 2022 totaled USD $25.08 million, representing a 14 percent increase as compared to USD $22.37 million for February 2022 and a 50 percent increase as compared to USD $16.82 million for March 2021.

The Company's cumulative consolidated sales revenues from January to March in 2022 were USD $66.76 million, a 46 percent increase as compared to USD $45.66 million for the same period in 2021.